Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share of Common Stock

v3.23.3
Net Loss per Share of Common Stock
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Net Loss per Share of Common Stock

Note 4 – Net Loss per Share of Common Stock

 

Net Loss Per Share

 

Basic net loss per share is computed by dividing our net loss available to common shareholders by the weighted average number of shares of common stock outstanding (which excludes unvested RSAs and includes vested RSUs) during the period. Diluted loss per share is computed by dividing our net loss available to common shareholders by the diluted weighted average number of shares of common stock (which includes the potentially dilutive effect of stock options, unvested RSAs, unvested RSUs and warrants) during the period. Since we experienced a net loss for all periods presented, basic and diluted net loss per share are the same. As such, diluted loss per share for the three- and nine-month periods ended September 30, 2023 and 2022 excludes the impact of potentially dilutive common shares since those shares would have an anti-dilutive effect on net loss per share.

 

 

The computation of net loss per share for the three- and nine-month periods ended September 30, 2023 and 2022 was as follows:

 

    2023     2022     2023     2022  
    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2023     2022     2023     2022  
Basic and diluted net loss per share:                                
Net loss available to common stockholders   $ (2,081,951 )   $ (6,020,410 )   $ (8,716,589 )   $ (14,411,909 )
Weighted average number of common shares-basic and diluted     27,002,908       16,200,222       25,585,222       15,991,653  
                                 
Basic and diluted net loss per share   $ (0.08 )   $ (0.37 )   $ (0.34 )   $ (0.90 )

 

Our diluted net loss per share for the three- and nine-month periods ended September 30, 2023 and 2022 excluded 5,798,035 and 2,760,527 of potentially dilutive common shares, respectively, related to outstanding stock options, stock purchase warrants and unvested restricted stock since those shares would have had an anti-dilutive effect on net loss per share during the periods then ended.